gene in people relapsing immediately after cure Together with the BCL2 antagonist venetoclax. 66 Resistance to those agents has been affiliated with these mutations in all around 70% of circumstances, although they usually are subclonal and their precise role creating resistance should be demonstrated.Genetic susceptibility mechanisms. Most suscept